Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Net Income towards Common Stockholders: 2019-2025

Historic Net Income towards Common Stockholders for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$37.9 million.

  • Benitec Biopharma's Net Income towards Common Stockholders fell 86.55% to -$8.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$37.9 million, marking a year-over-year decrease of 69.50%. This contributed to the annual value of -$37.9 million for FY2025, which is 69.50% down from last year.
  • According to the latest figures from FY2025, Benitec Biopharma's Net Income towards Common Stockholders is -$37.9 million, which was down 69.50% from -$22.4 million recorded in FY2024.
  • Benitec Biopharma's Net Income towards Common Stockholders' 5-year high stood at -$13.6 million during FY2021, with a 5-year trough of -$37.9 million in FY2025.
  • Over the past 3 years, Benitec Biopharma's median Net Income towards Common Stockholders value was -$22.4 million (recorded in 2024), while the average stood at -$26.6 million.
  • Data for Benitec Biopharma's Net Income towards Common Stockholders shows a maximum YoY tumbled of 69.50% (in 2025) over the last 5 years.
  • Benitec Biopharma's Net Income towards Common Stockholders (Yearly) stood at -$13.6 million in 2021, then crashed by 31.50% to -$17.9 million in 2022, then declined by 9.37% to -$19.6 million in 2023, then declined by 14.35% to -$22.4 million in 2024, then tumbled by 69.50% to -$37.9 million in 2025.